By Ben James ( August 27, 2007, 12:00 AM EDT) -- Celgene Corp. has filed another patent suit against Barr Pharmaceuticals Inc. in an attempt to stave off generic competition for its lucrative cancer treatment Thalomid, which brought in $117.7 million in net sales in the second quarter of 2007....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.